An Antiviral Accelerator
Providing rapid responses to emerging and current viral infections
impacting human health
Providing rapid responses to emerging and current viral infections
impacting human health
Our company understands that the most creative ideas arise from our international community of academic researchers. For rapid and innovative responses to viral infections, we collaborate with experts who have already dedicated decades of research to the pathogens of interest, as well as with experts on novel drug delivery systems. This rich collaboration between industry and academia accelerates the development of countermeasures against viral infections and allows their rapid deployment to patients in need.
Our team remains informed on the latest emerging and re-emerging viral infections impacting human health. We collaborate with academic experts to explore a range of therapies, including repurposed drugs, plant-based products, and antiviral nanoparticles. As a unified team, we bring therapies from bench to bedside through in vitro exploratory studies, in vivo proof-of-concept experiments, and clinical trials.
Copyright © 2022 Pharmavir, Inc. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.